Biosimilar News: Stada, Alvotech Launch the First Ustekinumab Biosimilar Across Europe
STADA and Alvotech have launched Uzpruvo, the first approved biosimilar to Ustekinumab (Stelara) in across a majority of European countries. Launches in further European countries are scheduled over the coming months, following national price approvals, via a fully European supply chain. “Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceutical markets, promotes access by […]